Korro Bio
PublicKorro Bio is now publicly traded
The data on this page reflects Korro Bio's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
PIPE
Apr 18, 2024
Total Funding Raised
$394.5M
Company Overview
Korro Bio operates in Biotech and is based in Cambridge, Massachusetts. It has raised $394.5M.
Korro Bio is a biopharmaceutical company focused on discovering, developing, and commercializing innovative genetic medicines that utilize RNA editing to treat both rare and common diseases with enhanced precision and flexibility.
Sector
Biotech
AI Layer
Non-AI
Korro Bio Comparables
Compare Korro Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AIRNA | 90% | |
| Serapha Bio | 81% | |
| AccurEdit Therapeutics | 76% |
For institutional investors. Book with your work email.
Korro Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| PIPE | Apr 18, 2024 | ||||
| Private Placement | Nov 3, 2023 | ||||
| Series B | Jan 5, 2022 | ||||
| Series A | Sep 10, 2020 | ||||
| Seed | Oct 7, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Korro Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sixty Degree Capital | Series B, Private Placement |
| MP Healthcare Venture Management | Series A, Series B, Private Placement |
| New Enterprise Associates | Seed, Series A, PIPE, Series B, Private Placement |
| Eventide Funds | Private Placement, Series B |
| Wu Capital | Series B, Series A |
| Fidelity Management & Research Company | Series B |
| Blue Owl Capital | PIPE |
For institutional investors. Book with your work email.
Korro Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.